Subtopic Deep Dive
Glucose-6-Phosphate Dehydrogenase Deficiency
Research Guide
What is Glucose-6-Phosphate Dehydrogenase Deficiency?
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzymopathy causing red blood cell vulnerability to oxidative stress, leading to hemolysis and severe neonatal hyperbilirubinemia.
G6PD deficiency affects the pentose phosphate pathway, reducing NADPH production essential for redox balance in erythrocytes (Luzzatto et al., 2020, 348 citations). Neonates with G6PD deficiency face heightened risks of jaundice from hemolytic triggers like infections or drugs (Maisels et al., 2009, 485 citations). Over 200 mutations worldwide impair enzyme function, with prevalence highest in malaria-endemic regions (Gómez-Manzo et al., 2016, 227 citations).
Why It Matters
G6PD deficiency drives severe neonatal jaundice, contributing to kernicterus risks in low-resource settings (Slusher et al., 2017, 220 citations; Bhutani et al., 2013, 480 citations). Targeted screening reduces phototherapy needs and prevents readmissions, as shown in Canadian incidence studies identifying unidentified causes in most cases (Sgro, 2006, 322 citations). Understanding G6PD's redox role informs antioxidant therapies and population-specific guidelines (Yang et al., 2019, 247 citations; van Wijk and van Solinge, 2005, 357 citations).
Key Research Challenges
Mutation Diversity Screening
Over 200 G6PD mutations vary by population, complicating universal neonatal screening (Gómez-Manzo et al., 2016, 227 citations). Phenotypic assays miss mild variants, risking undetected hemolysis risks. Genetic sequencing scales poorly in high-prevalence areas.
Trigger Identification Hemolysis
Oxidative triggers like fava beans or drugs precipitate neonatal jaundice unpredictably in G6PD-deficient infants (Luzzatto et al., 2020, 348 citations). Epidemiological data gaps hinder prevention in diverse regions (Bhutani et al., 2013, 480 citations). Real-time risk prediction models remain underdeveloped.
Hyperbilirubinemia Burden Estimation
Severe neonatal jaundice from G6PD causes underreported morbidity in low-income countries (Slusher et al., 2017, 220 citations). Global incidence estimates lack precision for policy (Bhutani et al., 2013, 480 citations). Longitudinal outcome tracking post-hemolysis is sparse.
Essential Papers
Beta-thalassemia
Antonio Cao, Renzo Galanello · 2010 · Genetics in Medicine · 629 citations
Hyperbilirubinemia in the Newborn Infant ≥35 Weeks’ Gestation: An Update With Clarifications
M. Jeffrey Maisels, Vinod K. Bhutani, Debra L. Bogen et al. · 2009 · PEDIATRICS · 485 citations
In July 2004, the Subcommittee on Hyperbilirubinemia of the American Academy of Pediatrics (AAP) published its clinical practice guideline on the management of hyperbilirubinemia in the newborn inf...
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
Vinod K. Bhutani, Alvin Zipursky, Hannah Blencowe et al. · 2013 · Pediatric Research · 480 citations
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
Richard van Wijk, Wouter W. van Solinge · 2005 · Blood · 357 citations
The red blood cell depends solely on the anaerobic conversion of glucose by the Embden-Meyerhof pathway for the generation and storage of high-energy phosphates, which is necessary for the maintena...
Glucose-6-phosphate dehydrogenase deficiency
Lucio Luzzatto, Mwashungi Ally, Rosario Notaro · 2020 · Blood · 348 citations
Abstract Glucose 6-phosphate dehydrogenase (G6PD) deficiency is 1 of the commonest human enzymopathies, caused by inherited mutations of the X-linked gene G6PD. G6PD deficiency makes red cells high...
Incidence and causes of severe neonatal hyperbilirubinemia in Canada
Michael Sgro · 2006 · Canadian Medical Association Journal · 322 citations
Severe neonatal hyperbilirubinemia continues to occur frequently in Canada. In the majority of cases, the underlying cause was not identified. The high readmission rate within days after initial di...
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer
Hung‐Chi Yang, Yi‐Hsuan Wu, Wei‐Chen Yen et al. · 2019 · Cells · 247 citations
The generation of reducing equivalent NADPH via glucose-6-phosphate dehydrogenase (G6PD) is critical for the maintenance of redox homeostasis and reductive biosynthesis in cells. NADPH also plays k...
Reading Guide
Foundational Papers
Start with Luzzatto et al. (2020) for G6PD mechanisms (348 citations), Maisels et al. (2009) for hyperbilirubinemia guidelines (485 citations), and van Wijk and van Solinge (2005) for erythrocyte glycolysis defects (357 citations).
Recent Advances
Study Gómez-Manzo et al. (2016) on global mutations (227 citations), Yang et al. (2019) on redox roles (247 citations), and Slusher et al. (2017) on jaundice burden (220 citations).
Core Methods
Core techniques include fluorescence-based enzyme assays, PCR for mutations, and nomograms for bilirubin risk (Maisels et al., 2009; Gómez-Manzo et al., 2016).
How PapersFlow Helps You Research Glucose-6-Phosphate Dehydrogenase Deficiency
Discover & Search
Research Agent uses searchPapers and exaSearch to find G6PD neonatal papers like 'Glucose-6-phosphate dehydrogenase deficiency' by Luzzatto et al. (2020), then citationGraph reveals clusters linking to Bhutani et al. (2013) on hyperbilirubinemia incidence, and findSimilarPapers uncovers related enzyme reviews such as van Wijk and van Solinge (2005).
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation data from Gómez-Manzo et al. (2016), verifies claims via verifyResponse (CoVe) against Sgro (2006) incidence stats, and runs PythonAnalysis for prevalence meta-analysis using pandas on Bhutani et al. (2013) datasets, with GRADE grading for evidence strength on screening efficacy.
Synthesize & Write
Synthesis Agent detects gaps in neonatal G6PD screening via contradiction flagging between Maisels et al. (2009) guidelines and Slusher et al. (2017) burden data, then Writing Agent uses latexEditText, latexSyncCitations for Luzzatto et al. (2020), and latexCompile to generate review manuscripts with exportMermaid diagrams of hemolytic pathways.
Use Cases
"Analyze G6PD prevalence and jaundice risk factors from top papers using Python stats."
Research Agent → searchPapers('G6PD neonatal hyperbilirubinemia') → Analysis Agent → readPaperContent(Bhutani 2013, Sgro 2006) → runPythonAnalysis(pandas meta-analysis of incidence rates) → researcher gets CSV of pooled prevalence with confidence intervals.
"Draft LaTeX review on G6PD mutations and neonatal outcomes."
Synthesis Agent → gap detection(Luzzatto 2020 + Gómez-Manzo 2016) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(all refs) → latexCompile → researcher gets compiled PDF with synced bibliography.
"Find code for G6PD enzyme modeling from related papers."
Research Agent → paperExtractUrls(van Wijk 2005) → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for glycolysis simulations linked to G6PD deficiency pathways.
Automated Workflows
Deep Research workflow scans 50+ G6PD papers via searchPapers → citationGraph → structured report on neonatal risks (Bhutani 2013). DeepScan applies 7-step CoVe checkpoints to verify hemolysis triggers from Luzzatto et al. (2020) against Sgro (2006). Theorizer generates hypotheses on mutation-specific jaundice models from Gómez-Manzo et al. (2016) enzyme data.
Frequently Asked Questions
What defines G6PD deficiency?
G6PD deficiency is an X-linked disorder from G6PD gene mutations reducing NADPH in red cells, causing oxidative hemolysis (Luzzatto et al., 2020).
What are key screening methods?
Neonatal screening uses quantitative enzyme assays or genetic tests; guidelines emphasize risk-based approaches for hyperbilirubinemia (Maisels et al., 2009; Sgro, 2006).
What are seminal papers?
Luzzatto et al. (2020, Blood, 348 citations) reviews clinical impacts; Bhutani et al. (2013, 480 citations) estimates global neonatal jaundice burden; Gómez-Manzo et al. (2016, 227 citations) catalogs mutations.
What open problems exist?
Challenges include scalable genotyping for 200+ mutations, predicting triggers in neonates, and reducing jaundice burden in low-resource settings (Slusher et al., 2017; Gómez-Manzo et al., 2016).
Research Neonatal Health and Biochemistry with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Glucose-6-Phosphate Dehydrogenase Deficiency with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Neonatal Health and Biochemistry Research Guide